Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
325
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

236
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
236

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

An Optimized Heart Failure Triaging Protocol to Reduce Avoidable Hospitalizations and Total Costs of Care.

NEJM catalyst innovations in care delivery·2026
Same author

The Ideal Trauma Transport Modality: Helicopter or Ground Ambulance? A Systematic Review and Meta-analysis.

Journal of emergencies, trauma, and shock·2026
Same author

Clinician and simulated patient perspectives on ambient AI scribes in psychiatric consultations: a qualitative study.

Frontiers in psychiatry·2026
Same author

Glycemic Control and Diabetes Outcomes After Surgical Therapy for Diabetic Gastroparesis.

JAMA surgery·2026
Same author

Autoimmune Encephalitis Masquerading As Acute Psychosis: A Cause of Delayed Treatment.

Cureus·2026
Same author

A Rare Case of Semaglutide-Associated Small Bowel Obstruction Complicated by Acute Kidney Injury Requiring Dialysis.

Cureus·2026

相关实验视频

Updated: Jul 1, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K

多重耐药结核病腹膜炎:一个病例报告

Rhea Verma1, Clinton Sonier2, Nida Rizvi2

  • 1Medicine, Drexel University College of Medicine, Philadelphia, USA.

Cureus
|March 12, 2024
PubMed
概括

这份案例报告强调了一名患有腹部结核病和同时感染艾滋病毒的年轻男性. 这一复杂的病例涉及耐药结核病以及诸如败血栓和肺栓塞等并发症.

关键词:
亚酸是一种酸.艾滋病毒感染者虹膜 虹膜 虹膜 虹膜它具有多种药物耐药性.膜炎是一种膜炎.结核病是一种肺结核病.

更多相关视频

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.9K

相关实验视频

Last Updated: Jul 1, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.9K

科学领域:

  • 内部医学 内部医学
  • 传染性疾病 传染性疾病
  • 肺部病理学 肺部病理学

背景情况:

  • 全球结核病 (TB) 发病率正在上升,腹部结核病是最常见的肺外结核病形式.
  • 同时感染人类免疫缺陷病毒 (HIV) 会使结核病的诊断和治疗变得复杂.
  • 免疫复原炎症综合征 (IRIS) 可能发生在同时感染的患者中.

研究的目的:

  • 详细介绍一个患有腹部结核病和同时感染艾滋病毒的年轻男性的诊断挑战和管理.
  • 为了说明这种共感染的临床表现,诊断工作和治疗复杂性.
  • 强调在结核病管理中考虑耐药性的重要性.

主要方法:

  • 病例报告详细介绍患者的诊断旅程.
  • 临床表现:夜间出汗,减肥,艾滋病毒诊断,CD4计数无法检测.
  • 诊断调查:成像 (淋巴腺病症),支气管镜检查 (肺结核),血清血症,白蛋白梯度 (SAAG),淋巴结活检 (AFB).

主要成果:

  • 发现了腹部淋巴腺病和肺结核.
  • 结核病腹膜炎的诊断通过低SAAG和在淋巴结中呈阳性酸快菌根 (AFB) 得到证实.
  • 患者经历了败血性休克,双边肺栓塞和.
  • 药物耐药性对异化和乙醇复杂治疗.

结论:

  • 艾滋病毒阳性个体的腹部结核病带来了诊断和治疗方面的挑战.
  • 早期识别和综合管理至关重要,特别是在耐药性方面.
  • 在ART开始后出现症状恶化的同时感染患者中,应考虑IRIS.